Cerebrospinal fluid synaptic biomarker changes in bipolar disorder – A longitudinal case-control study
Authors:
- Ulla KnorrUKUlla Knorr
- Henrik ZetterbergHZHenrik Zetterberg
- Kaj BlennowKBKaj Blennow
Open Access
- 7 May 2024
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 358, 250-259
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Deep proteomics identifies shared molecular pathway alterations in synapses of patients with schizophrenia and bipolar disorder and mouse modelCell Reports, 2023
- Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction are Altered in Parkinson's Disease and Related DisordersMovement Disorders, 2022
- Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disordersAlzheimer's & Dementia, 2022
- Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegenerationJournal of Neural Transmission, 2021
- Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic reviewEuropean Neuropsychopharmacology, 2018
- Neurocognitive features in clinical subgroups of bipolar disorder: A meta-analysisJournal of Affective Disorders, 2018
- Structural and metabolic differentiation between bipolar disorder with psychosis and substance-induced psychosis: An integrated MRI/PET studyEuropean Psychiatry, 2016
- Plasma β-amyloid peptides levels: A pilot study in bipolar depressed patientsJournal of Affective Disorders, 2012
- Conceptualization and Rationale for Consensus Definitions of Terms in Major Depressive DisorderArchives of General Psychiatry, 1991
- SCANArchives of General Psychiatry, 1990